Standex (NYSE:SXI) Exceeds Q2 CY2026 Expectations
Industrial manufacturer Standex (NYSE: SXI) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 2.8% year on year to $228.3 million. Its non-GAAP profit of $2.45 per share was 4.1% above analysts’ consensus estimates. Is now the time to buy Standex? Find out by accessing our full research report, it’s free.
How this was made

The 30-second read
Why it matters
For traders, the key decision inputs are the magnitude of the Q2 beat versus consensus, the stability of operating margin, and the stated forward growth expectations that may influence near-term estimates.
Market read
A Q2 revenue and non-GAAP EPS beat with stable margins supports the earnings narrative, but decelerating expected revenue growth and an EBITDA miss temper upside.
What to watch
The forward revenue growth expectation (5.4%) decelerates versus the last two years, and the stock is described as flat immediately after results, suggesting the market may already price in quality.
Background
The article summarizes Standex’s Q2 CY2026 performance, highlighting revenue and non-GAAP EPS beats, segment growth, and leverage reduction.
Ticker impact
Standex (SXI) reported Q2 revenue of $228.3M (+2.8% YoY) and non-GAAP EPS $2.45, both above analysts’ expectations.
Likely supports a modest upside bias versus consensus, but the article’s note of flat post-results price implies limited incremental repricing.
The text provides concrete Q2 results versus consensus (revenue +1% beat, EPS +4.1% beat) plus a forward EPS range, while also flagging mixed signals like EBITDA miss and only 5.4% expected revenue growth.
Market effects
Electronics and fast-growth markets strength (book-to-bill and organic growth) is a positive read-through for industrial component demand.
No regional demand or macro linkage is provided in the article.
No global supply-chain or international regulatory impacts are disclosed.
Counterpoint
Despite the EPS and revenue beat, the article flags an EBITDA miss and only modest YoY revenue growth, which can cap multiple expansion.
Key entities
- companyStandex
Industrial manufacturer reporting Q2 CY2026 results and providing segment and balance-sheet commentary.
- personDavid Dunbar
President and CEO quoted on organic growth, book-to-bill, and leverage.

